| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52f14ac74eacfb038a07853e1084ab59 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2017-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9d8df60bb5742cdfce35293c4574b9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d159925bc6a22b2aa77425da48f3976
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aacfc95dee5513d6fdf0ff8aaba57a2 |
| publicationDate |
2017-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CL-2017001024-A1 |
| titleOfInvention |
Formulation of injectable buprenorphine |
| abstract |
<p> THIS INVENTION PROVIDES AN INJECTABLE LIQUID FORMULATION THAT INCLUDES: AT LEAST ONE OXYGEN CONTAINING ORGANIC SOLVENT; AT LEAST 16% BY WEIGHT OF AT LEAST A SELECTED ACTIVE AGENT OF BUPRENORFINE AND SALTS OF THE SAME, CALCULATED AS A BUPRENORFINE FREE BASE. THE INVENTION ALSO PROVIDES A CONTROLLED RELEASE COMPOSITION, FORMED BY THE ADMINISTRATION OF SUCH INJECTABLE LIQUID COMPOSITION TO A PREFERIBLY HUMAN SUBJECT. THE INVENTION ALSO PROVIDES A BUPRENORFINE METHOD OF ADMINISTRATION TO A SUBJECT THAT INCLUDES INJECTING SUCH LIQUID COMPOSITION AND A METHOD FOR THE TREATMENT OF PAIN, FOR OPIOID MAINTENANCE THERAPY, OR FOR THE PROCESSING OF THE OPTIMAL AND DISPENSE PROCESSING MAINTENANCE OR FOR THE TREATMENT OR PROFILAXIS OF SYMPTOMS OF OPIOID ABSTINENCE AND / OR COCAINE ABSTINENCE INJECTING SUCH LIQUID COMPOSITION. </p> |
| priorityDate |
2014-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |